Lilly and Hims & Hers deal puts Zepbound and Foundayo on the Hims platform
Lilly and US telehealth firm Hims & Hers say patients prescribed on the Hims platform can now get Zepbound (tirzepatide) and the Foundayo pill there at Lilly's self-pay prices, from $149 a month for Foundayo and $299 for Zepbound. Hims has committed not to offer compounded copies of Lilly's GLP-1s. It is a US-only deal, but it shows Lilly pushing harder into direct-to-patient online channels.
Source: Eli Lilly (6 Nov 2026).